Drawing for ONCOSTEM

USPTO serial 79032406

ONCOSTEM

Reviewed by CopyMark Law Group

Reg. 3335540Status 404
Filing date
Status date
Registration date
Nov 13, 2007
Examiner
BRODY, DANIEL S
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ONCOSTEM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Todd A. Denys

TODD A. DENYS MATTHEWS SHEPHERD MCKAY & BRUNEAU PA29 THANET ROAD SUITE 201PRINCETON, NJ 08540-3674UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-cancer preparations; pharmaceutical products and vaccines for the treatment of viral and infectious diseases, for the prevention and treatment of cancer; radiopharmaceutical imaging and detection agents for diagnosis and monitoring cancer; radioactive substances for use in nuclear medicine; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticalsSECTION 71 - CANCELLED—
042MEDICAL AND SCIENTIFIC RESEARCH IN THE FIELD OF CANCER PREVENTION, TREATMENT AND DIAGNOSIS AND IN THE FIELD OF MEDICAL IMAGING; DEVELOPMENT OF PHARMACEUTICAL PREPARATIONS AND MEDICINES IN THE FIELD OF CANCER PREVENTION, TREATMENT AND DIAGNOSIS; ANALYSIS OF THE MODE OF ACTION OF CHEMICAL COMBINATIONS ON ANIMALS; BIOLOGICAL CLONING SERVICES; PHARMACEUTICAL DRUG DEVELOPMENT SERVICES, PHARMACEUTICAL RESEARCH AND DEVELOPMENT; RESEARCH AND DEVELOPMENT OF VACCINES AND MEDICINES; RESEARCH, DEVELOPMENT AND CONSULTATION RELATED THERETO IN THE FIELD OF CANCER PREVENTION, TREATMENT AND DIAGNOSIS; SCIENTIFIC INVESTIGATIONS FOR MEDICAL PURPOSES; SCIENTIFIC RESEARCH IN THE FIELD OF GENETICS AND GENETIC ENGINEERINGSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 9, 2017UNDNUNDELIVERABLE MAIL - NO ACTION TAKEN—
May 19, 2017DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
May 19, 2017DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 24, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jun 30, 2015XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jun 30, 2015XXCRGENERIC MADRID TRANSACTION CREATED—
Feb 20, 2015INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 20, 2014C71TCANCELLED SECTION 71—
Jun 5, 2009FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 19, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 19, 2008FIMPFINAL DISPOSITION PROCESSED—
Feb 13, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 13, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 28, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 8, 2007NPUBNOTICE OF PUBLICATION—
Jul 24, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 24, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 19, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
Jul 19, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 18, 2007ALIEASSIGNED TO LIE—
Jun 29, 2007MAILPAPER RECEIVED—
Mar 29, 2007RFNPREFUSAL PROCESSED BY IB—
Mar 8, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 8, 2007RFRRREFUSAL PROCESSED BY MPU—
Mar 7, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 6, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 5, 2007DOCKASSIGNED TO EXAMINER—
Jan 5, 2007NWAPNEW APPLICATION ENTERED—
Dec 28, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance